Aneuploidy, the somatic mutation that makes cancer a species of its own

Cell Motility and the Cytoskeleton

Volumn 47, Issue 2, 2000, Pages 81-107

  Brokaw, Charles J ^a,b  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b Kerckhoff Marine Laboratory   (United States)

Author keywords

Aneuploidy; Aneuploidy catalyzed chromosome reassertment; Cancer; Gene mutation; Speciation

Indexed keywords

ANEUPLOIDY; CHROMOSOME DAMAGE; GENE MUTATION; GENETIC STABILITY; HUMAN; HUMAN CELL; KARYOTYPE; MATHEMATICAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ECHINOIDEA;

EID: 0033815915     PISSN: 08861544     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0169(200010)47:2<81::aid-cm1>3.0.co;2-%23     Document Type: Review

References (229)

1. Aneuploidy: A report of an ECETOC task force
2. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality
3. Transforming ras genes from human melanoma: A manifestation of tumor heterogeneity?
4. Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection
5. The age distribution of cancer and a multi-stage theory of carcinogenesis
6. Reflections on the declining ability of the Salmonella assay to detect rodent carcinogens as positive
7. Are human cancers ever diploid, or often trisomic?. Conflicting evidence from direct preparations and cultures
8. Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro
9. Life is complicated
10. Role of genetic instability in carcinogenesis
11. Charactersitics of 'hybrid'-type clonal cell lines obtained from mixed cultures in vitro
12. Roentgenausloesung von Chromosomen Mutationen bei Drosophila melanogaster
13. Non-random retinoblastoma gene is a recessive cancer gene
14. An experimental study of the initiating stage of carcinogenesis, and a re-examination of the somatic cell mutation theory of cancer
15. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals
16. Enemies within: Genesis of retrovirus oncogenes
17. Cancer: The rise of the genetic paradigm
18. How many mutations does it take to make a tumor?
19. Sarcomas routinely produced from putatively nontumorigenic Balb/3T3 and C3H/10T1/2 cells by subcutaneous inoculation attached to plastic platelets
20. Radiation oncogenesis in cell culture
21. Neoplastic transformation of hamster embryo cells irradiated in utero and assayed in vitro
22. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease
23. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice
24. On multipolar mitosis as a means of analysis of the cell nucleus
25. Mutagenesis by chemical agents in V79 chinese hamster cells: A review and analysis of the literature. A report of the Gene-Tox Program
26. Isolation and characterization of thymidine transport mutants of Chinese hamster cells
27. Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected
28. Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: Relation between carcinogenic potential of hydrocarbons and their binding to deoxyribonucleic acid
29. The significance of mutation in relation to origin of tumors
30. Dominant effects of tubulin overexpression in Saccharomyces cerevisiae
31. Mutations of mitotic checkpoint genes in human cancers
32. Genetic instability and darwinian selection in tumours
33. Cytochemical differences between mammalian cell lines of normal and neoplastic origins: Correlation with heterotransplantability in Syrian hamsters
34. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic H-ras1 gene mutations
35. Aneuploidy in mammalian somatic cells in vivo
36. Rate of somatic mutation in immunoglobulin production by mouse myeloma cells
37. Karyotype analysis of carcinogen-treated Chinese hamster cells in vitro evolving from a normal to a malignant phenotype
38. Aneuploidy, an early event in mouse skin tumor development
39. Kinetics of multi-enzyme systems
40. Spontaneous neoplastic evolution of Chinese hamster cells in culture: Multistep progression of karyotype
41. Induction of chronic myelogenous leukemia in mice by the P210(-bcr/abl) gene of the Philadelphia Chromosome
42. Karyological instability of neoplastic somatic cells
43. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
44. Oncogenes and Cancer
45. Are centrosomes or aneuploidy the key to cancer?
46. Genetic instability of cancer cells is proportional to their degree of aneuploidy
47. How aneuploidy may cause cancer and genetic instability
48. Aneuploidy precedes, and segregates with chemical carcinogenesis
49. Retroviruses as carcinogens and pathogens: Expectations and reality
50. Latent viruses and mutated oncogenes: No evidence for pathogenicity
51. Differences between the ribonucleic acids of transforming and non-transforming avian tumor viruses
52. Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate
53. Neoplasia and cytogenetic abnormalities
54. Clonal origin of human tumors
55. Multiple etiologic factors in neoplastic development
56. Abnormal centrosome amplification in the absence of p53
57. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancer
58. Toxic effects of excess cloned centromeres
59. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia
60. Chemically induced aneuploidy in mammalian cells in culture
61. Aneuploidy and ageing: Chromosome studies on a random sample of the population using G-banding
62. Genetics of mammalian cell cultures
63. Patterns of genomic imbalances in human solid tumors
64. Bloom's syndrome. II. The prototype of genetic disorders predisposing to chromosome instability and cancer
65. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations
66. Intratumor heterogeneity of K-ras mutations in colorectal adenocarcinomas
67. A model of DNA aneuploidization and evolution in colorectal cancer
68. Evidence that retroviral transduction is mediated by DNA, not by RNA
69. Activation of cellular genes by avian RNA tumor viruses
70. The promise of cancer genetics
71. Creation of human tumour cells with defined genetic elements
72. The genetics of cancer
73. Supplementary chapter by editor: General conclusions
74. Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression
75. Dissecting multistep tumorigenesis in transgenic mice
76. The hallmarks of cancer
77. Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung
78. A bcr-v-abl oncogene induces lymphomas in transgenic mice
79. Chromosomes and neoplasia
80. Cytogenetically marked clones in human fibroblasts cultured from normal subjects
81. Chemical and physical carcinogenesis: Advances and perspective for the 1990s
82. How tumor suppressor genes were discovered
83. Defects in cell cycle checkpoint may be responsible for the genomic instability of cancer cells
84. Chromosome abnormalities in human reproductive wastage
85. The chromosomes in ontogeny and oncogeny
86. Giebt es eine primaere zur Geschwulstbildung fuehrende Epithelerkrankung? Ein Beitrag zur Geschwulstlehre
87. The limited in vitro lifetime of human diploid cell strains
88. Structural organization of the bcr gene and its role in the Ph' translocation
89. The cellular basis of tumor progression
90. Polyploidy: More is more or less
91. Chromosome error propagation and cancer
92. Database of p53 gene somatic mutations in human tumors and cell lines
93. The impact of aneuploidy upon public health: Mortality and morbidity associated with human chromosome abnormalities
94. Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers
95. Cancer biology: Comparative and genetic
96. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations for a bacterial transgene target
97. Spontaneous and induced chromosomal aberrations and gene mutations in human lymphoblasts: Mitomycin C, methylnitrosourea, and ethylnitrosourea
98. Effects of benzo[a]pyrene and trans-7,8-dihydroxy-7,8-dihydrobenzo-[a]pyrene on mitosis in Chinese hamster V79 cells with stable expression of rat cytochrome P4501A1 or 1A2
99. Primary vs. secondary neoplasia-associated chromosomal abnormalities: Balanced rearrangements vs. genomic imbalances?
100. The molecular basis of dominance
101. Transmnission of chromosomal instability after plutonium α-particle irradiation
102. Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia
103. Lessons from hereditary cancer
104. Chemical transformation of Chinese hamster cells: II. Appearance of marker chromosomes in transformed cells
105. Hereditary cancer, oncogenes, and antioncogenes
106. Chronic myelogenous leukemia: New concepts (second of two parts)
107. Chronic myelogenous leukemia: New concepts. Part I
108. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma
109. Heterogeneity of p53 mutational status in esophaeal cell carcinoma
110. Avian tumor virus RNA: A comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization
111. Polyploidy in angiosperms
112. Le Mongolisme, premier exemple d'abberation autosomique humaine
113. Genetic instability in colorectal cancers
114. Role of chromosomes in cancerogenesis, as studied in serial tissue culture of mammalian cells
115. Induction of cytogenetic effects in human fibroblast cultures after exposure to formal-dehyde or X-rays
116. Host range restrictions of oncogenes: myc genes transform avian but not mammalian cells and mht/raf genes transform mammalian but not avian cells
117. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells
118. Aneuploidy versus gene mutation hypothesis of cancer: Recent study claims mutation, but is found to support aneuploidy
119. Chemical probes and possible targets for the induction of aneuploidy
120. A view of the relation between carcinogenesis and mutagenesis
121. Segmental aneuploidy and the genetic gross structure of the Drosophila genome
122. Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity
123. Radiation carcinogenesis
124. Mutator phenotype may be required for multistage carcinogenesis
125. Transient expression of a mutator phenotype in cancer cells
126. The secrets of cancer
127. Die Veraenderungen der Haeufigkeit euploider und aneuploider Chromosomenzahlen in der hepatektomierten Rattenleber bei Buttergelb-Verfuetterung
128. Rous sarcoma virus: A function required for the maintenance of the transformed state
129. Aneuploidy induction by benzo[a]pyrene and polyploidy induction by 7,12-dimethylbenz[a]anthracene in Chinese hamster cell lines V79-MZ and V79
130. The chromosomes of the vertebrates
131. Rapid structural and epigenetic changes in polyploid and aneuploid genomes
132. On the elimination of the X-chromosome from the egg of Drosophila melanogaster by X-rays
133. High levels of chromosome instability in polyploids of Saccharomyces cerevisiae
134. Chromosomal imbalance maps of malignant solid tumors: A cytogentic survey of 3185 neoplasms
135. Chemical carcinogenesis: Mechanisms and approaches to its control
136. The Rous sarcoma virus story: Cytogenetics of tumors induced by RSV
137. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia
138. The relationship of DNA ploidy to chromosomal instability in primary human colorectal cancers
139. The origin of gynandromorphs
140. The genetics of Drosophila
141. Artificial transmutation of the gene
142. Unexpected sensitivity to the induction of mutations by very low doses of alpha-particle radiation: Evidence for a bystander effect
143. Relationship between cell killing, chromosomal aberrations, sister-chromatid exchanges and point mutations induced by monofunctional alkylating agents in Chinese hamster cells; A correlation with different ethylation products in DNA
144. A minute chromosome in human chronic granulocytic leukemia
145. The clonal evolution of tumor cell populations
146. Cytogenetics
147. The promise of comparative genomics in mammals
148. Mechanistic aspects on chemical induction of spindle disturbances and abnormal chromosome numbers
149. p53 gene mutations are not required for early dissemination of cancer cells
150. Mutagenesis to aminopterin resistance in cultured hamster cells
151. A checkpoint on the road to cancer
152. Chemically induced aneuploidy in mammalian cells: Mechanisms and biological significance in cancer
153. The detection and assessment of the aneugenic potential of environmental chemicals: The European Community Aneuploidy Project
154. The detection and evaluation of aneugenic chemicals
155. Trigger for centrosome replication found
156. Centrosome defects and genetic instability in malignant tumors
157. Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells
158. Mechanisms of chemical carcinogenesis
159. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene
160. How aneuploidy affects metabolic control and causes cancer
161. Auto-catalysed progression of aneuploidy explains the Hayflick limit of cultured cells, carcinogen-induced tumours in mice, and the age distribution of human cancer
162. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene
163. Primary culture of rat mammary epithelial cells. II. Cytotoxic effect and metabolism of 7,12-dimethylbenz[a]anthracene and N-nitroso-N- methylurea
164. Surmise and fact on the nature of cancer
165. The challenge to man of the neoplastic cell
166. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quiacrine fluorescence and Giemsa staining
167. Molecular heterogeneity in prostate cancer: Can TP53 mutation unravel tumorigenesis?
168. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis
169. Therapeutic and prognostic value of initial chromosomal findings at the blastic phase of Ph-positive chronic myeloid leukemia
170. Chromosomal characteristics of chronic and blastic phases of ph-positive chronic myeloid leukemia
171. Aneuploidy in the degenerative phase of serial cultivation of human cell strains
172. Oncogene-induced liver neoplasia in transgenic mice
173. Genetic effects of aneuploidy
174. Molecular cytogenetics of multiple drug resistance
175. DNA recombination is sufficient for retroviral transduction
176. Tumor initiation and promotion
177. Biological properties of human c-Ha-ras1 genes mutated at codon 12
178. Down syndrome: A disruption of homeostasis
179. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas
180. On the nature of heritable variation in cultured somatic cells
181. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo
182. The effects of chemotherapy on the kinetics of leukemic cell behavior
183. Human tumor suppressor genes
184. The origin of point mutations in human tumor cells
185. Aneuploidy and progression in promoted preneoplastic foci during hepatocarcinogenesis in the rat
186. Mechanism of activation of a human oncogene
187. Chromosomal variation and the origin of drug-resistant mutants in mammalian cell lines
188. Detection of transforming genes from radiation transformed human epidermal keratinocytes by a tumor-igenicity assay
189. Mechanisms involved in the immortalization of mammalian cells by inonizing radiation and chemical carcinogens
190. Tumor immunity
191. Genetic alterations during colorectal-tumor development
192. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice
193. Rebuilding the road to cancer
194. Somatic mutation as a factor in the production of cancer; a critical review of v. Hansemann's theory of anaplasia in the light of modern knowledge of genetics
195. Zytologische Untersuchungen ueber die Natur maligner Tumoren. II. Teerkarzinome bei Maeusen
196. Theodor Boveri and his book 'On the problem of the origin of malignant tumors'
197. Karyotype progression in human tumors
198. Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells
199. Karyotype evolution and tumor development
200. Gene expression profiles in normal and cancer cells
201. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation